Utah Medical Products UTMD Intrinsic value of stock options exercised
Intrinsic value of stock options exercised at other companies
Other financials
Where this comes from
Reported directly by Utah Medical Products in its filing.
Tagged under the XBRL concept us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue.
The official record: Utah Medical Products’s 10-K, filed March 27, 2026, on SEC EDGAR. View the filing →
Ask your AI about Utah Medical Products's intrinsic value of stock options exercised.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Utah Medical Products's intrinsic value of stock options exercised?
- Utah Medical Products (UTMD) reported intrinsic value of stock options exercised of $0 in Q4 2025.
- How has Utah Medical Products's intrinsic value of stock options exercised changed year-over-year?
- Utah Medical Products's intrinsic value of stock options exercised decreased by 100.0% year-over-year, from $19.25K to $0.
- What is the long-term trend for Utah Medical Products's intrinsic value of stock options exercised?
- Over 4 years (2021 to 2025), Utah Medical Products's intrinsic value of stock options exercised has grown at a -100.0% compound annual growth rate (CAGR), from $591K to $0.
- What does intrinsic value of stock options exercised mean?
- The total intrinsic value realized by employees upon the exercise of stock options during the period, calculated as the difference between the market price at exercise and the option strike price. This reflects the actual economic benefit captured by employees from their equity incentives. It is a measure of the historical performance and retention value of the company's stock option plans.